Anti-OX40 has been demonstrated to improve tumor free survival in mice and is now moving past the first Phase 1 study. Ludovic Bourre, Director of Scientific Engagement for Crown Bio Science outlines the what has been seen so far with OX40.
What has been Demonstrated From Targeting OX40
